Chemical Structure (Gabapentin)
Chemical structure diagram of Gabapentin showing a cyclohexane ring with attached amino and carboxyl functional groups.*
Gabapentin
Product Images NDC 43353-731
9 FDA label images from Aphena Pharma Solutions - Tennessee, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 43353-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (24ec031b 505b 49e7 9dce 6b383426cb0a 02)
A line graph depicting mean pain scores over 8 weeks comparing Gabapentin 3600 mg/day and placebo. The x-axis represents time in weeks including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows the mean pain score from 0 to 10. Gabapentin shows a decline in pain score over time, while placebo remains relatively constant.*
Figure 2 (24ec031b 505b 49e7 9dce 6b383426cb0a 03)
A line graph depicting mean pain scores over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The chart illustrates pain score changes during a 3-week dose titration period followed by a 4-week fixed dose period, showing reduced pain scores in Gabapentin groups relative to placebo.*
Figure 3 (24ec031b 505b 49e7 9dce 6b383426cb0a 04)
A bar chart compares the percentage of responders at endpoint in two studies evaluating Gabapentin (GBP) at different doses (3600 mg, 1800 mg, and 2400 mg) against placebo (PBO). Study 1 shows 12% response for placebo and 29% for GBP 3600 mg. Study 2 shows 14% response for placebo and 32% and 34% for GBP 1800 mg and 2400 mg, respectively, with p-values indicating statistical significance.*
Figure 4 (24ec031b 505b 49e7 9dce 6b383426cb0a 05)
A scatter plot chart presenting data from three studies labeled 'STUDY a,' 'STUDY b,' and 'STUDY c.' The x-axis shows daily dose in mg (600, 900, 1200, 1800), and the y-axis shows difference in percentage from 2 to 22%. Each study's data points are represented by different colored squares: black for STUDY a, gray for STUDY b, and white for STUDY c, showing variation in difference percentage at each dose level.*
Bottle Label 300mg (43353 709)
Label for Gabapentin 300mg capsules, package containing 90 capsules. Label includes storage instructions, manufacturer Invagen Pharmaceuticals Inc., Hauppauge, NY, and repackager Aphena Pharma Solutions - Tennessee, Inc., Cookeville, TN. The label also shows NDC 43353-0709-60 and states RX only.*
Bottle Label 400mg (43353 710)
Label for Gabapentin 400 mg capsules, containing 90 capsules. The label includes storage instructions, manufacturer Invagen Pharmaceuticals Inc. in Hauppauge, NY, and repackager Aphena Pharma Solutions - Tennessee, Inc. in Cookeville, TN. It is an Rx-only product with NDC 43353-0710-60.*
Bottle Label 100mg (43353 731)
Label for Gabapentin 100mg capsules, containing 270 capsules. The label includes storage instructions, manufacturer Invagen Pharmaceuticals Inc., Hauppauge, NY, and repackager Aphena Pharma Solutions - Tennessee, Inc., Cookeville, TN. It specifies RX only and features multiple barcodes and batch/lot number fields.*
Aphena Pharma Solutions (TN)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
